Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transglutaminase 2 promotes epithelial-to-mesenchymal transition by regulating the expression of matrix metalloproteinase 7 in colorectal cancer cells via the MEK/ERK signaling pathway.
Blaheta RA, Han J, Oppermann E, Bechstein WO, Burkhard K, Haferkamp A, Rieger MA, Malkomes P. Blaheta RA, et al. Among authors: burkhard k. Biochim Biophys Acta Mol Basis Dis. 2025 Jan;1871(1):167538. doi: 10.1016/j.bbadis.2024.167538. Epub 2024 Oct 9. Biochim Biophys Acta Mol Basis Dis. 2025. PMID: 39389321 Free article.
Forensic, legal, and clinical aspects of deaths associated with implanted cardiac devices.
Federspiel JM, Potente S, Abeln KB, Hennemann K, Heinbuch S, Burkhard K, Richl M, Kettner M, Lux C, Schmidt P, Verhoff MA, Ramsthaler F. Federspiel JM, et al. Among authors: burkhard k. Front Psychiatry. 2023 Nov 28;14:1278078. doi: 10.3389/fpsyt.2023.1278078. eCollection 2023. Front Psychiatry. 2023. PMID: 38090699 Free PMC article. Review.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
22 results